Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA
School of Population Health, Curtin University, Perth, Western Australia, Australia.
Occup Environ Med. 2022 Dec;79(12):795-806. doi: 10.1136/oemed-2022-108371. Epub 2022 Oct 7.
Given mixed evidence for carcinogenicity of current-use herbicides, we studied the relationship between occupational herbicide use and risk of non-Hodgkin's lymphoma (NHL) in a large, pooled study.
We pooled data from 10 case-control studies participating in the International Lymphoma Epidemiology Consortium, including 9229 cases and 9626 controls from North America, the European Union and Australia. Herbicide use was coded from self-report or by expert assessment in the individual studies, for herbicide groups (eg, phenoxy herbicides) and active ingredients (eg, 2,4-dichlorophenoxyacetic acid (2,4-D), glyphosate). The association between each herbicide and NHL risk was estimated using logistic regression to produce ORs and 95% CIs, with adjustment for sociodemographic factors, farming and other pesticides.
We found no substantial association of all NHL risk with ever-use of any herbicide (OR=1.10, 95% CI: 0.94 to 1.29), nor with herbicide groups or active ingredients. Elevations in risk were observed for NHL subtypes with longer duration of phenoxy herbicide use, such as for any phenoxy herbicide with multiple myeloma (>25.5 years, OR=1.78, 95% CI: 0.74 to 4.27), 2,4-D with diffuse large B-cell lymphoma (>25.5 years, OR=1.47, 95% CI: 0.67 to 3.21) and other (non-2,4-D) phenoxy herbicides with T-cell lymphoma (>6 years, lagged 10 years, OR=3.24, 95% CI: 1.03 to 10.2). An association between glyphosate and follicular lymphoma (lagged 10 years: OR=1.48, 95% CI: 0.98 to 2.25) was fairly consistent across analyses.
Most of the herbicides examined were not associated with NHL risk. However, associations of phenoxy herbicides and glyphosate with particular NHL subtypes underscore the importance of estimating subtype-specific risks.
鉴于当前使用的除草剂致癌性的证据不一,我们在一项大型的汇总研究中,研究了职业性除草剂使用与非霍奇金淋巴瘤(NHL)风险之间的关系。
我们汇总了国际淋巴瘤流行病学联盟(International Lymphoma Epidemiology Consortium) 10 项病例对照研究的数据,包括来自北美、欧盟和澳大利亚的 9229 例病例和 9626 例对照。在个别研究中,除草剂的使用情况是根据自我报告或专家评估来编码的,包括除草剂组(如苯氧除草剂)和有效成分(如 2,4-二氯苯氧乙酸(2,4-D)、草甘膦)。使用逻辑回归估计每种除草剂与 NHL 风险之间的关联,以产生比值比(OR)和 95%置信区间(CI),并根据社会人口因素、农业和其他杀虫剂进行调整。
我们发现,使用任何除草剂与 NHL 总风险之间没有实质性关联(OR=1.10,95%CI:0.94 至 1.29),也与除草剂组或有效成分无关。在苯氧除草剂使用时间较长的 NHL 亚型中,观察到风险升高,例如,任何苯氧除草剂与多发性骨髓瘤(>25.5 年,OR=1.78,95%CI:0.74 至 4.27)、2,4-D 与弥漫性大 B 细胞淋巴瘤(>25.5 年,OR=1.47,95%CI:0.67 至 3.21)和其他(非 2,4-D)苯氧除草剂与 T 细胞淋巴瘤(>6 年,滞后 10 年,OR=3.24,95%CI:1.03 至 10.2)。草甘膦与滤泡性淋巴瘤之间的关联(滞后 10 年:OR=1.48,95%CI:0.98 至 2.25)在各项分析中基本一致。
大多数除草剂与 NHL 风险无关。然而,苯氧除草剂和草甘膦与特定 NHL 亚型之间的关联强调了估计特定亚型风险的重要性。